Cost-Utility Study of PCV13 Versus PPSV23 in Adults in ChileESTUDIO DE COSTO-UTILIDAD DE PCV13 Versus PPSV23 EN ADULTOS EN CHILE

ConclusionPCV13 is dominant. A PCV13 vaccination program saves costs to the public system, reduces mortality and morbidity; these results are robust.
Source: Value in Health Regional Issues - Category: International Medicine & Public Health Source Type: research